EPISODE · Jan 20, 2021 · 10 MIN
GRACECast - LCVL - Can patients with an EGFR mutation-positive advanced NSCLC benefit from immunotherapy
from GRACEcast - Discussions with the Global Resource for Advancing Cancer Education · host cancerGRACE
Dr. Dr. Joel Neal discusses patients with an EGFR mutation positive advanced non small cell lung cancer and if they can benefit from immunotherapy.
Embed this episode
NOW PLAYING
GRACECast - LCVL - Can patients with an EGFR mutation-positive advanced NSCLC benefit from immunotherapy
0:00
10:39
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of GRACEcast - Discussions with the Global Resource for Advancing Cancer Education?
This episode is 10 minutes long.
When was this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode published?
This episode was published on January 20, 2021.
Can I download this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!